Promoting Health, Safety and Equity

Harm Reduction Innovation Lab

401-212-4730

  • Home
  • About Us
    • What is Harm Reduction?
    • Meet the Team
    • Mission, Vision, & Values
    • Contact Us
  • Research Projects
    • Drug Checking
    • OD Detection Technologies
    • Sleep and MOUD
    • Completed Projects
  • Publications and Posters
    • Publications
    • Research Posters
    • Select Presentations
  • Resources
    • Infographics
    • Additional Websites
  • Español
    • Inicio
    • Reducción de Danos
    • Conoce al Equipo
    • Misión, Visión & Valores
    • Trabajos de Investigación
    • Publicaciones y Posteres
    • Recursos
  • More
    • Home
    • About Us
      • What is Harm Reduction?
      • Meet the Team
      • Mission, Vision, & Values
      • Contact Us
    • Research Projects
      • Drug Checking
      • OD Detection Technologies
      • Sleep and MOUD
      • Completed Projects
    • Publications and Posters
      • Publications
      • Research Posters
      • Select Presentations
    • Resources
      • Infographics
      • Additional Websites
    • Español
      • Inicio
      • Reducción de Danos
      • Conoce al Equipo
      • Misión, Visión & Valores
      • Trabajos de Investigación
      • Publicaciones y Posteres
      • Recursos
Harm Reduction Innovation Lab

401-212-4730

  • Home
  • About Us
    • What is Harm Reduction?
    • Meet the Team
    • Mission, Vision, & Values
    • Contact Us
  • Research Projects
    • Drug Checking
    • OD Detection Technologies
    • Sleep and MOUD
    • Completed Projects
  • Publications and Posters
    • Publications
    • Research Posters
    • Select Presentations
  • Resources
    • Infographics
    • Additional Websites
  • Español
    • Inicio
    • Reducción de Danos
    • Conoce al Equipo
    • Misión, Visión & Valores
    • Trabajos de Investigación
    • Publicaciones y Posteres
    • Recursos

Research Posters

Characteristics of Drug Checking Programs in 2022: Findings from the North American Drug Checking Survey

Stakeholders’ Perspectives on the Role of Stigma in Authorizing & Implementing Safe Consumption Sites in the United States: A Qualitative Study

Stakeholders’ Perspectives on the Role of Stigma in Authorizing & Implementing Safe Consumption Sites in the United States: A Qualitative Study

View

Stakeholders’ Perspectives on the Role of Stigma in Authorizing & Implementing Safe Consumption Sites in the United States: A Qualitative Study

Stakeholders’ Perspectives on the Role of Stigma in Authorizing & Implementing Safe Consumption Sites in the United States: A Qualitative Study

Stakeholders’ Perspectives on the Role of Stigma in Authorizing & Implementing Safe Consumption Sites in the United States: A Qualitative Study

View

Validation of Rapid Fentanyl and Xylazine Test Strips & FT-IR Spectroscopy for Use in Community Based Settings

Stakeholders’ Perspectives on the Role of Stigma in Authorizing & Implementing Safe Consumption Sites in the United States: A Qualitative Study

Enabling & Constraining Forces on the Operation & Implementation of Drug Checking Programs in Latin America: A Qualitative Study

View

Enabling & Constraining Forces on the Operation & Implementation of Drug Checking Programs in Latin America: A Qualitative Study

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

Enabling & Constraining Forces on the Operation & Implementation of Drug Checking Programs in Latin America: A Qualitative Study

View

Overdose Detection Technologies for People Who Use Alone

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

VIEW

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

VIEW

Characteristics Associated With Fentanyl Test Strip Use Among People Who Use Drugs in Rhode Island (2021-2023)

Characteristics Associated With Fentanyl Test Strip Use Among People Who Use Drugs in Rhode Island (2021-2023)

Characteristics Associated With Fentanyl Test Strip Use Among People Who Use Drugs in Rhode Island (2021-2023)

VIEW

Restroom Motion Sensor Systems to Prevent Overdose: Pilot Findings from Rhode Island

Characteristics Associated With Fentanyl Test Strip Use Among People Who Use Drugs in Rhode Island (2021-2023)

Characteristics Associated With Fentanyl Test Strip Use Among People Who Use Drugs in Rhode Island (2021-2023)

VIEW
  • Contact Us

Harm Reduction Innovation Lab

1125 North Main Street, Providence, Rhode Island 02904, United States

401-212-4730

Copyright © 2024 Harm Reduction Innovation Lab - All Rights Reserved.

Powered by